Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Innar Tõru

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal of Psychopharmacology (Oxford, England)|July 21, 2004
The effect of 5-hydroxytryptophan on cholecystokinin-4-induced panic attacks in healthy volunteersEduard Maron, Innar Tõru, Veiko Vasar, et al.
Nordic Journal of Psychiatry|May 5, 2017
Association between personality traits and Escitalopram treatment efficacy in panic disorderÜlle Võhma, Mait Raag, Innar Tõru, et al.
Psychopharmacology|March 17, 2006
Tryptophan depletion does not modify response to CCK-4 challenge in patients with panic disorder after treatment with citalopramInnar Tõru, Jakov Shlik, Eduard Maron, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 24, 2004
Growth hormone, cortisol and prolactin responses to physical exercise: higher prolactin response in depressed patientsEvelyn Kiive, Jaak Maaroos, Jakov Shlik, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|September 4, 2004
Association between serotonin-related genetic polymorphisms and CCK-4-induced panic attacks with or without 5-hydroxytryptophan pretreatment in healthy volunteersEduard Maron, Gunnar Tasa, Innar Tõru, et al.
Nordic Journal of Psychiatry|March 4, 2024
Reliability and validity of the Estonian version of the Clinical Institute of Withdrawal Assessment for Alcohol scaleTeelia Rolko, Teve Rauks-Pärgmäe, Anu Aluoja, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 4, 2012
The effect of 6-week treatment with escitalopram on CCK-4 challenge: a placebo-controlled study in CCK-4-sensitive healthy volunteersInnar Tõru, Eduard Maron, Mait Raag, et al.
Nordic Journal of Psychiatry|April 25, 2018
Personality traits and escitalopram treatment outcome in major depressionAnu Aluoja, Innar Tõru, Mait Raag, et al.
Neuroscience Letters|October 4, 2008
Association testing of panic disorder candidate genes using CCK-4 challenge in healthy volunteersEduard Maron, Innar Tõru, Gunnar Tasa, et al.
Psychiatry Research|May 18, 2010
Associations between personality traits and CCK-4-induced panic attacks in healthy volunteersInnar Tõru, Anu Aluoja, Ulle Võhma, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Psychopharmacology (Oxford, England)|July 21, 2004
The effect of 5-hydroxytryptophan on cholecystokinin-4-induced panic attacks in healthy volunteersEduard Maron, Innar Tõru, Veiko Vasar, et al.
Nordic Journal of Psychiatry|May 5, 2017
Association between personality traits and Escitalopram treatment efficacy in panic disorderÜlle Võhma, Mait Raag, Innar Tõru, et al.
Psychopharmacology|March 17, 2006
Tryptophan depletion does not modify response to CCK-4 challenge in patients with panic disorder after treatment with citalopramInnar Tõru, Jakov Shlik, Eduard Maron, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 24, 2004
Growth hormone, cortisol and prolactin responses to physical exercise: higher prolactin response in depressed patientsEvelyn Kiive, Jaak Maaroos, Jakov Shlik, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|September 4, 2004
Association between serotonin-related genetic polymorphisms and CCK-4-induced panic attacks with or without 5-hydroxytryptophan pretreatment in healthy volunteersEduard Maron, Gunnar Tasa, Innar Tõru, et al.
Nordic Journal of Psychiatry|March 4, 2024
Reliability and validity of the Estonian version of the Clinical Institute of Withdrawal Assessment for Alcohol scaleTeelia Rolko, Teve Rauks-Pärgmäe, Anu Aluoja, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 4, 2012
The effect of 6-week treatment with escitalopram on CCK-4 challenge: a placebo-controlled study in CCK-4-sensitive healthy volunteersInnar Tõru, Eduard Maron, Mait Raag, et al.
Nordic Journal of Psychiatry|April 25, 2018
Personality traits and escitalopram treatment outcome in major depressionAnu Aluoja, Innar Tõru, Mait Raag, et al.
Neuroscience Letters|October 4, 2008
Association testing of panic disorder candidate genes using CCK-4 challenge in healthy volunteersEduard Maron, Innar Tõru, Gunnar Tasa, et al.
Psychiatry Research|May 18, 2010
Associations between personality traits and CCK-4-induced panic attacks in healthy volunteersInnar Tõru, Anu Aluoja, Ulle Võhma, et al.
Pageof 2